LET'S TALK. 877-341-5968

Regenexx Corporate Overview for Meritain Broker Partners

We’re holding two sessions. Select the date & time that is the most convenient for you.

Why Join Us?

Orthopedic diseases cost $980 billion annually and typically make up 20% of health plan spending. Regenexx has created a new medical specialty, Interventional Orthopedics. Using precise image-guided injections of orthobiologics, this treatment replaces the need for up to 70% of elective orthopedic surgeries and saves self-funded plans up to 70% compared to individual orthopedic surgeries.

During this 45 min. webinar, Jason Hellickson, of Regenexx Corporate, will join us in hosting a webinar for Meritain Broker Partners that walks through the Regenexx cost-savings program for self-funded employers. Key learning objectives are outlined below.

  1. Understand the current state of musculoskeletal care and the costs involved.
  2. Distinguish between orthopedic surgery and interventional orthopedics.
  3. Identify the key issues a fiduciary must consider when deciding on adding an intervention to a health plan.
  4. Learn about the communication strategies that help create employee engagement.

Submit the form below to register for the webinar.